Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
NCT02371447Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Sep 2015
- Primary completion
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of recombinant BCG in non-muscle-invasive bladder cancer (NMIBC), sponsored by Swiss Group for Clinical Cancer Research. Started Sep 2015; status: completed.
02
Drugs
recombinant BCG
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT02371447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371447.